From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus
- PMID: 28118527
- DOI: 10.1002/acr.23199
From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus
Abstract
Objective: To determine the longitudinal damage trajectory of patients with juvenile-onset systemic lupus erythematosus (SLE), and to identify baseline and disease course predictors of damage trajectory.
Methods: This is a retrospective inception cohort. Longitudinal pediatric-age data were obtained from a juvenile-onset SLE research database, while adult-age data were obtained from either a research database or patients' charts. Baseline factors were tested as predictors. Time-varying factors were lagged 6-24 months before a visit for testing their predictive effects. The longitudinal damage trajectory was modeled using a weighted generalized estimating equation.
Results: This study cohort consisted of 473 subjects, with followup to 26 years. A total of 65% of patients were ages >18 years at last followup. Cataracts (14%), avascular necrosis (10%), and osteoporosis (5%) were the most common items of damage. Two patients had myocardial infarctions. Baseline features, self-reported ethnicity (Afro-Caribbean), earlier time periods of diagnosis, and the presence of a life-threatening major organ manifestation (lupus nephritis class III-V, cerebrovascular accidents, major organ vasculitis, pulmonary hemorrhage, or myocarditis), were associated with greater damage. Throughout the disease course, an acute confusional state, lupus headache, and fever predicted subsequent increases in the damage trajectory. A higher prednisone dose and exposure to cyclophosphamide also predicted subsequent increases in the damage trajectory. Antimalarial exposure was protective against an increase in damage trajectory.
Conclusion: Patients with juvenile-onset SLE accrue damage steadily into adulthood. Baseline factors predict greater damage and/or influence the evolution of the damage trajectory. Additionally, SLE clinical features and therapies during the course of disease predict additional changes in the damage trajectory.
© 2017, American College of Rheumatology.
Similar articles
-
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.Arthritis Rheum. 2012 Jul;64(7):2356-65. doi: 10.1002/art.34410. Arthritis Rheum. 2012. PMID: 22294381
-
Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus.Semin Arthritis Rheum. 2019 Oct;49(2):267-272. doi: 10.1016/j.semarthrit.2019.05.010. Epub 2019 Jun 3. Semin Arthritis Rheum. 2019. PMID: 31235075 Free PMC article.
-
From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus.Arthritis Care Res (Hoboken). 2018 May;70(5):750-757. doi: 10.1002/acr.23319. Epub 2018 Mar 25. Arthritis Care Res (Hoboken). 2018. PMID: 28704581
-
Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.Rheumatology (Oxford). 2007 Aug;46(8):1290-6. doi: 10.1093/rheumatology/kem102. Epub 2007 May 23. Rheumatology (Oxford). 2007. PMID: 17522097 Review.
-
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis.Lupus. 2011 Nov;20(13):1345-55. doi: 10.1177/0961203311416694. Epub 2011 Sep 27. Lupus. 2011. PMID: 21951943
Cited by
-
Changing paradigms in the treatment of systemic lupus erythematosus.Lupus Sci Med. 2019 Feb 8;6(1):e000310. doi: 10.1136/lupus-2018-000310. eCollection 2019. Lupus Sci Med. 2019. PMID: 31168398 Free PMC article.
-
Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.Lupus. 2018 Aug;27(9):1532-1541. doi: 10.1177/0961203318779710. Epub 2018 Jun 28. Lupus. 2018. PMID: 29954282 Free PMC article.
-
Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus.Pediatr Nephrol. 2023 Jun;38(6):1843-1854. doi: 10.1007/s00467-022-05811-y. Epub 2022 Nov 21. Pediatr Nephrol. 2023. PMID: 36409367
-
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.Ther Adv Musculoskelet Dis. 2022 Feb 14;14:1759720X211073001. doi: 10.1177/1759720X211073001. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35186126 Free PMC article. Review.
-
Growing up with chronic pain: a systematic review of the evidence in transitional care for young people with chronic pain.Rheumatol Adv Pract. 2023 Mar 24;7(Suppl 1):i19-i25. doi: 10.1093/rap/rkad006. eCollection 2023 Apr. Rheumatol Adv Pract. 2023. PMID: 36968631 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical